Uni-Bio Science Group Limited
UNBSF
$0.0036
$0.00360.00%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.32% | 2.34% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.32% | 2.34% | |||
| Cost of Revenue | 0.32% | 13.88% | |||
| Gross Profit | 0.32% | 0.19% | |||
| SG&A Expenses | 0.32% | 22.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -0.29% | 6.39% | |||
| Total Operating Expenses | 0.32% | 23.81% | |||
| Operating Income | 0.32% | -58.00% | |||
| Income Before Tax | 0.32% | -72.50% | |||
| Income Tax Expenses | 0.33% | 2.03% | |||
| Earnings from Continuing Operations | 0.31% | -77.10% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.31% | -77.10% | |||
| EBIT | 0.32% | -58.00% | |||
| EBITDA | 0.32% | -57.47% | |||
| EPS Basic | 0.00% | -71.43% | |||
| Normalized Basic EPS | 0.00% | -80.00% | |||
| EPS Diluted | 0.00% | -71.43% | |||
| Normalized Diluted EPS | 0.00% | -80.00% | |||
| Average Basic Shares Outstanding | 0.00% | -0.76% | |||
| Average Diluted Shares Outstanding | 0.00% | -0.76% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||